Cancer drug developer Parthenon Therapeutics secured the funding in a series A round co-led by Pfizer Ventures and Taiho Ventures.

Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.

Google, Kroger and SoftBank Vision Fund 1 all contributed to the autonomous vehicle developer's series D round at a reported $8.6bn valuation.

Gilead and BeiGene participated in a round for the immuno-oncology therapeutics developer in a round that came seven months after it raised $43m.

FTX helped Chipper add $150m to a series C round valuing the cross-border payment platform developer at over $2bn.

Alphabet’s CapitalG unit returned for the legal data platform developer's latest round, which was led by TPG Growth at a $2bn valuation.

The NFT-based metaverse platform developer's latest round was led by SoftBank Vision Fund 2 and included Animoca Brands, LG Technology Ventures, Polygon Studios and Samsung Next.

Lotte Ventures was among the participants in an $88.4m round which will help the mobility platform developer increase headcount and strengthen its technology.

SoftBank Vision Fund 2 led a series C round for the progmmatic advertising software developer that increased its total funding to $105m.

The energy provider's National Grid Partners unit has deployed a total of $24m to Cogniac, AptEdge, Finite State, TS Conductor, Sync Computing and Risilience